The Studies of Prognostic Factors and the Genetic Polymorphism of Methylenetetrahydrofolate Reductase C667T in Thymic Epithelial Tumors
ObjectiveTo describe the clinical features of a cohort of patients with thymic epithelial tumors (TETs) and to analyze their prognostic factors. In particular, we investigated the correlation between the genetic polymorphism of methylenetetrahydrofolate reductase (MTHFR) C667T and the incidence of T...
Main Authors: | Miaolong Yan, Jiayuan Wu, Min Xue, Juanfen Mo, Li Zheng, Jun Zhang, Zhenzhen Gao, Yi Bao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.847957/full |
Similar Items
-
TNM Staging System in Thymoma: A Critical Appraisal?
by: Marcello Carlo Ambrogi, et al.
Published: (2024-01-01) -
Masaoka-Koga and TNM Staging System in Thymic Epithelial Tumors: Prognostic Comparison and the Role of the Number of Involved Structures
by: Marco Chiappetta, et al.
Published: (2021-10-01) -
Changes to the 8th Edition AJCC: Staging Head and Neck Cancer
by: Frank Pameijer
Published: (2022-11-01) -
Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand
by: Chaiwat Aphivatanasiri, et al.
Published: (2022-09-01) -
Prognostic importance of the outcomes of updating staging system in patients with stage II breast cancer
by: Hasan Dagmura, et al.
Published: (2020-09-01)